Principal Financial Group Inc. Lowers Stock Position in Trupanion, Inc. $TRUP

Principal Financial Group Inc. cut its stake in shares of Trupanion, Inc. (NASDAQ:TRUP) by 38.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 165,796 shares of the financial services provider’s stock after selling 102,407 shares during the quarter. Principal Financial Group Inc.’s holdings in Trupanion were worth $4,246,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans lifted its holdings in Trupanion by 1.1% during the second quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock valued at $1,376,000 after purchasing an additional 282 shares in the last quarter. EP Wealth Advisors LLC lifted its position in shares of Trupanion by 2.9% in the second quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock valued at $571,000 after acquiring an additional 292 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Trupanion by 2.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock worth $1,258,000 after acquiring an additional 725 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Trupanion by 3.8% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after acquiring an additional 737 shares during the period. Finally, CANADA LIFE ASSURANCE Co grew its position in shares of Trupanion by 3.1% during the third quarter. CANADA LIFE ASSURANCE Co now owns 35,522 shares of the financial services provider’s stock worth $1,556,000 after purchasing an additional 1,057 shares in the last quarter.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 6,177 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the transaction, the chief financial officer directly owned 2,081 shares of the company’s stock, valued at approximately $46,156.58. This trade represents a 74.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the sale, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. This represents a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,376 shares of company stock valued at $383,642 in the last ninety days. Corporate insiders own 5.58% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on TRUP. Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. Stifel Nicolaus set a $28.00 price target on Trupanion in a research note on Friday, June 26th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Bank of America reduced their price objective on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th. Finally, Cantor Fitzgerald lowered their target price on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a report on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $41.60.

Trupanion Trading Up 2.5%

Shares of TRUP stock opened at $25.50 on Wednesday. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $57.00. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The stock’s 50-day moving average price is $24.14 and its 200-day moving average price is $26.64. The stock has a market capitalization of $1.11 billion, a price-to-earnings ratio of 43.22 and a beta of 1.39.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. During the same period in the previous year, the business earned ($0.03) earnings per share. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. Equities research analysts predict that Trupanion, Inc. will post 0.55 EPS for the current fiscal year.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.